-
Eur Rev Med Pharmacol Sci · Jan 2021
ReviewRemdesivir as a broad-spectrum antiviral drug against COVID-19.
- Y-N Hong, J Xu, G B K Sasa, K-X Zhou, and X-F Ding.
- Zhejiang Sci-Tech University, Zhejiang, HangZhou, China. bdd114@163.com.
- Eur Rev Med Pharmacol Sci. 2021 Jan 1; 25 (1): 541-548.
ObjectiveList the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility.Materials And MethodsThe keywords of "remdesivir", "COVID-19" and "SARS-CoV-2" were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19.ResultsIn this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug.ConclusionsAccording to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.